Approval · Notice of Compliance 14260 · 2013
EUGLUCON: Notice of Compliance 14260
Issued March 28, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14260
- Date
- March 28, 2013
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New drug substance manufacturer
- Therapeutic class
- Oral hypoglycemic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EUGLUCON | Not yet assigned | — |
Medicinal ingredients
- GLYBURIDE 5 MG per TAB